Insecticides (India) Ltd. Submits Annual Secretarial Compliance Report for FY26
Insecticides (India) Limited has filed its Annual Secretarial Compliance Report for FY26. The report confirms compliance with SEBI regulations, including an inter-se share transfer within the promoter group, for which SEBI granted an exemption from open offer obligations on December 02, 2025. A minor penalty was paid for a buy-back record date deviation.
This is a routine annual compliance report. The mentioned deviation and penalty are minor and have already been addressed, with no significant impact expected on the company's operations or financials.
The announcement is a routine compliance filing. While it mentions a past deviation and penalty, it also confirms overall compliance and SEBI's exemption, making the sentiment neutral.
Insecticides (India) Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by Akash Gupta & Associates, Company Secretaries, confirms the company's compliance with various SEBI regulations.
Key aspects reviewed include compliance with SEBI Act, SCRA, LODR Regulations, 2015, and Takeovers Regulations, 2011. Notably, during the review period, an inter-se transfer of shares within the Promoter Group, pursuant to a family arrangement, attracted provisions of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The acquirers had sought and obtained exemption from SEBI for an open offer, with SEBI granting the exemption on December 02, 2025, subject to certain conditions. The acquirers confirmed compliance with these conditions on February 10, 2026.
The report also highlights a minor deviation concerning the record date for a Buy-Back, which was initially set for September 11, 2024, falling within 30 days of the previous record date of August 23, 2024. This led to a penalty of ₹10,000 plus GST each levied by the BSE and NSE, which has been paid by the company. The company also informed investors of this non-conformity.
Furthermore, the report confirms the company's compliance with Secretarial Standards, adoption and timely updation of policies, maintenance of a functional website with timely dissemination of information, and preservation of documents. It also states that none of the Directors are disqualified under Section 164 of the Companies Act, 2013. The company has not identified any material subsidiary companies, though it listed IL Biologicals Limited, IIL Overseas DMCC (Dubai - dissolved), and Kaeros Research Limited as its subsidiaries. The company also confirmed compliance with related party transaction approvals and disclosure requirements for events or information under Regulation 30.
What to do with a filing like this
Insecticides (India) Limited filed this with the NSE as a statutory disclosure, categorised under secretarial compliance report. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Insecticides (India) Limited. Read the original for the full detail.